Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines

BACKGROUND: Doxorubicin (DOX) is widely used in both human and veterinary oncology although the onset of multidrug resistance (MDR) in neoplastic cells often leads to chemotherapy failure. Better understanding of the cellular mechanisms that circumvent chemotherapy efficacy is paramount. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Levi, Michela, Salaroli, Roberta, Parenti, Federico, De Maria, Raffaella, Zannoni, Augusta, Bernardini, Chiara, Gola, Cecilia, Brocco, Antonio, Marangio, Asia, Benazzi, Cinzia, Muscatello, Luisa Vera, Brunetti, Barbara, Forni, Monica, Sarli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814552/
https://www.ncbi.nlm.nih.gov/pubmed/33461558
http://dx.doi.org/10.1186/s12917-020-02709-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814552/
https://www.ncbi.nlm.nih.gov/pubmed/33461558
http://dx.doi.org/10.1186/s12917-020-02709-5

Ejemplares similares